论文信息 - ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer - 字舞流文

ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer

B. Monk | N. Senzer | J. Nemunaitis | S. Brun | R. Coleman | T. Herzog | G. Wallraven | R. Rocconi | L. Stanbery | L. Manning | E. Bognar | S. Horvath | Adam Walter | M. Tang